Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Many patients use GLP-1 injections for a set period before transitioning to maintenance support
First approved to treat MDS-related anemia in 2020 in patients who failed to respond to an erythropoiesis-stimulating (ESA) agentthe established front-line treatmentthe treatment will now be available to patients who have not received ESA therapy
Learning as much as you can about GLP-1s before your appointment can also help
Semaglutide already has approved uses for certain patients
US$ 25.12
US$ 22.70
US$ 26.80
US$ 21.75
